Back to Search
Start Over
Novel neuroprotective therapy with NeuroHeal by autophagy induction for damaged neonatal motoneurons.
- Source :
-
Theranostics [Theranostics] 2020 Apr 06; Vol. 10 (11), pp. 5154-5168. Date of Electronic Publication: 2020 Apr 06 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Rationale : Protective mechanisms allow healthy neurons to cope with diverse stresses. Excessive damage as well as aging can lead to defective functioning of these mechanisms. We recently designed NeuroHeal using artificial intelligence with the goal of bolstering endogenous neuroprotective mechanisms. Understanding the key nodes involved in neuroprotection will allow us to identify even more effective strategies for treatment of neurodegenerative diseases. Methods : We used a model of peripheral nerve axotomy in rat pups, that induces retrograde apoptotic death of motoneurons. Nourishing mothers received treatment with vehicle, NeuroHeal or NeuroHeal plus nicotinamide, an inhibitor of sirtuins, and analysis of the pups were performed by immunohistochemistry, electron microscopy, and immunoblotting. In vitro , the post-translational status of proteins of interest was detailed using organotypic spinal cord cultures and genetic modifications in cell lines to unravel the neuroprotective mechanisms involved. Results : We found that the concomitant activation of the NAD <superscript>+</superscript> -dependent deacetylase SIRT1 and the PI3K/AKT signaling pathway converge to increase the presence of deacetylated and phosphorylated FOXO3a, a transcription factor, in the nucleus. This favors the activation of autophagy, a pro-survival process, and prevents pro-apoptotic PARP1/2 cleavage. Major conclusion : NeuroHeal is a neuroprotective agent for neonatal motoneurons that fine-tunes autophagy on by converging SIRT1/AKT/FOXO3a axis. NeuroHeal is a combo of repurposed drugs that allow its readiness for prospective pediatric use.<br />Competing Interests: Competing Interests: The authors have declared that no competing interest exists. NeuroHeal is currently under patent protection.<br /> (© The author(s).)
- Subjects :
- Animals
Artificial Intelligence
Autophagy
Cells, Cultured
Disease Models, Animal
Drug Combinations
Motor Neurons pathology
Rats
Rats, Sprague-Dawley
Signal Transduction
Acamprosate pharmacology
Forkhead Box Protein O3 metabolism
Motor Neurons drug effects
Neuroprotective Agents pharmacology
Phosphatidylinositol 3-Kinases metabolism
Ribavirin pharmacology
Sirtuin 1 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1838-7640
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Theranostics
- Publication Type :
- Academic Journal
- Accession number :
- 32308774
- Full Text :
- https://doi.org/10.7150/thno.43765